Yoon, Jeong Hee http://orcid.org/0000-0002-9925-9973
Park, Jin Young http://orcid.org/0000-0003-2713-4490
Lee, Sang Min http://orcid.org/0000-0001-7719-3849
Lee, Eun Sun http://orcid.org/0000-0003-0780-7985
Kim, Jae Hyun http://orcid.org/0000-0002-6691-3932
Lee, Jeong Min http://orcid.org/0000-0003-0561-8777
Funding for this research was provided by:
Riyeon Pharmaceuticals (grant No 1902-023-1008)
Article History
Received: 24 July 2023
Accepted: 21 September 2023
First Online: 19 October 2023
Declarations
:
: This prospective study was approved by the institutional review board of Seoul National University Hospital (IRB No: H-1902-023-1008). Written informed consent was obtained in all participants.
: Not applicable.
: Jeong Hee Yoon: Honoraria from Accuzen, Bayer and Philips Healthcare. Consulting fee from Bayer. Jeong Min Lee: Grant from Bayer, Bracco, Canon, Central Medical Servis, Dongkuk Pharma, GE Healthcare, Guerbet, Philips Healthcare, Samsung Medison, Siemens Healthineers; Consulting fees from Sansumg medison; Honoraria from Bayer, Claripi, GE Healthcare, Guerbet, Philips Healthcare, Samsung Medison, Siemens Healthineers. Other authors (J.Y.P., S.M.L., E.S.L., J.H.K.) declared no competing interests.